The demand for guidewires is projected to grow at a CAGR of 6.1% during the forecast period (2023-2032). The global guidewires market size is projected to surpass US$ 1,755 Mn by the end of 2033, up from US$ 968 Mn in 2023.
The use of minimally invasive surgery is on the rise, and this, together with improvements in surgical technology, is expected to drive the growth of the global guidewires market. The prevalence of the target ailment is expanding, major manufacturers are introducing new products often, and developed countries offer favorable guidewire medical reimbursement rates.
Download a Sample Copy of This Report:https://www.factmr.com/connectus/sample?flag=S&rep_id=4682?PJ
The examiners have utilized various vast conspicuous business knowledge devices to unite realities, figures, and market information into income assessments and projections in the Market.
Key partners in Market including industry players, policymakers, and financial backers in different nations have been persistently realigning their systems and ways to deal with carry out them to take advantage of new open doors. Numerous lately have updated their procedures to stay coordinated in the setting of overall disturbances brought about by the COVID-19 pandemic.
Global Guidewires: Market Segmentation
Fact.MR has studied the global guidewires market with detailed segmentation on the basis of product, end user and key regions.
- By Product :
- Coronary Guidewires
- Peripheral Guidewires
- Neurovascular Guidewires
- Urology Guidewires
- Radiology Guidewires
- Gastroenterology Guidewires
- Other Guidewires (Otolarynology & Oncology)
- By End-user :
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
- By Key Regions :
- North America
- Europe
- Asia Pacific
- Eastern Europe
- Latin America
- Middle East & Africa (MEA)
Key Companies Profiled
- Boston Scientific Corporation
- Terumo Corporation
- Cardinal Health Inc.
For coronary and vascular interventional procedures, Terumo Interventional Systems, a competitor in the market, offers hydrophilic and cutting-edge hybrid guidewires with nitinol cores. The Long Taper GLIDEWIRE, the J-tip GLIDEWIRE, and the GLIDEWIRE TORQUETM Device are some of its products. These guidewires offer unrivaled retention and lubricity. This guarantees uniformity throughout the entire process.
-
- The FDA approved Cardiovascular Systems Inc.’s ViperWire Advance Coronary Guide Wire in October 2019. Diamondback 360 orbital atherectomy system is a feature of the newly developed guidewire, allowing for better navigation and therapeutic results.
- Cardiovascular Systems signs an agreement with OrbusNeich and Integer in January 2018. The business made the strategic choice to increase the range of premium balloon and guidewire products it offers.
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
- EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
- CIS & Russia
- Japan
- Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
How Fact.MR Assists in Making Strategic Moves?
The data provided in the Guidewires Market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.
The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.